Frontlight ResearchEarly access
Duchenne muscular dystrophy trials in United States
15 of 35 trials · From ClinicalTrials.gov, checked 18 November 2026. Ask the study team whether a trial fits you.
- No phaseEnrolling by invitationA Long-term Observational Study Evaluating Eteplirsen, Golodirsen, or Casimersen in Routine Clinical Practice
- Where
- Baltimore, Charlottesville, Cincinnati, Columbus, Durham, Fort Worth, Gainesville, Hershey, Houston, Iowa City, Kansas City, Little Rock, Los Angeles, New York, Orange, Philadelphia, Pittsburgh, Sacramento, Seattle, St Louis, The Bronx, Washington D.C., Winston-Salem
- People
- 300
- Run by
- Sarepta Therapeutics, Inc.
See details and how to joinNCT06606340 - No phaseTaking peopleDuchenne Electronic Health Record Study
- Where
- Aurora, Dallas, Durham, Iowa City, Little Rock, New Haven, Sacramento, Salt Lake City, Seattle, Washington D.C.
- People
- 2,500
- Run by
- The Duchenne Registry
See details and how to joinNCT07609394 - No phaseTaking peopleBiomarker Development for Muscular Dystrophies
- Where
- Boston, Pittsburgh, Winston-Salem
- Age
- 5 years and over
- People
- 465
- Run by
- Massachusetts General Hospital
See details and how to joinNCT05019625 - No phaseEnrolling by invitationAn Observational Study Comparing Delandistrogene Moxeparvovec (ELEVIDYS) With Standard of Care in Participants With Duchenne Muscular Dystrophy
- Where
- Akron, Albuquerque, Ann Arbor, Aurora, Birmingham, Boston, Charlottesville, Chicago, Durham, Fort Worth, Hartford, Hershey, Indianapolis, Kansas City, Little Rock, Los Angeles, Louisville, Madison, Miami, Milwaukee, Nashville, Norfolk, Orlando, Philadelphia, Portland, Seattle, Stony Brook, St. Petersburg, Washington D.C.
- Age
- 4 years and over
- People
- 500
- Run by
- Sarepta Therapeutics, Inc.
See details and how to joinNCT06270719 - No phaseTaking peopleRegistry Study to Observe Long-term Safety of Vamorolone (AGAMREE®) in Patients With Duchenne Muscular Dystrophy-SUMMIT
- Where
- Charlotte, Charlottesville, Chicago, Cincinnati, Dallas, Denton, Durham, Gainesville, Grand Rapids, Hershey, Indianapolis, Kansas City, Little Rock, Loma Linda, Los Angeles, Madera, Miami, Milwaukee, Minneapolis, North Worcester, Orlando, Palo Alto, Philadelphia, Phoenix, Sacramento, San Antonio, Seattle, St. Petersburg, The Bronx, Washington D.C.
- Age
- 2 years and over
- People
- 250 worldwide
- Run by
- Catalyst Pharmaceuticals, Inc.
See details and how to joinNCT06564974 - No phaseTaking peopleThe Baby Duchenne Study: Characterizing Developmental and Clinical Outcomes in the First Three Years in Children With Duchenne Muscular Dystrophy
- Where
- Cincinnati, Columbus, Rochester, Stony Brook
- Age
- 0 days to 3 years
- People
- 105
- Run by
- University of Rochester
See details and how to joinNCT07092540 - No phaseTaking peopleModeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Identification of Surrogate Outcome Measures for DMD Drug Trials
- Where
- Chicago, Columbus, Durham, Indianapolis, Nashville, Richmond, Sacramento, Seattle, Washington D.C.
- People
- 1,000
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT07674758 - No phaseTaking peopleA Study Evaluating the Real-World Experience of Givinostat in Patients With Duchenne Muscular Dystrophy
- Where
- Boston, Chicago, Durham, Little Rock, New York, Portland, Seattle, Washington D.C., Worcester
- Age
- 6 years and over
- People
- 300
- Run by
- ITF Therapeutics LLC
See details and how to joinNCT07127978 - No phaseTaking peopleWearable Technology to Evaluate Hyperglycemia and HRV in DMD
- Where
- Nashville
- Age
- 10 years and over
- People
- 80
- Run by
- Vanderbilt University Medical Center
See details and how to joinNCT06124196 - No phaseTaking peopleThe Duchenne Registry
- Where
- Washington D.C.
- People
- 10,000
- Run by
- The Duchenne Registry
See details and how to joinNCT02069756 - No phaseTaking peopleEstablishing Walking-related Digital Biomarkers in Rare Childhood Onset Progressive Neuromuscular Disorders
- Where
- Boston, New York, Palo Alto
- Age
- 5 years and over
- People
- 106
- Run by
- Columbia University
See details and how to joinNCT06839469 - No phaseEnrolling by invitationLong Term Follow-up for RGX-202
- Where
- Chicago, Dallas, Little Rock, Palo Alto, Richmond
- People
- 66
- Run by
- REGENXBIO Inc.
See details and how to joinNCT06491927 - No phaseEnrolling by invitationDerivation of Human Induced Pluripotent Stem (iPS) Cells to Heritable Cardiac Arrhythmias
- Where
- Baltimore
- Age
- 18 years to 85 years
- People
- 100
- Run by
- Johns Hopkins University
See details and how to joinNCT02413450 - No phaseTaking peopleDMD Voice: Qualitative Interviews With Patients and Caregivers
- Where
- Yardley
- Age
- 10 years and over
- People
- 68
- Run by
- Red Nucleus Enterprise Solutions, LLC
See details and how to joinNCT06925269 - No phaseTaking peopleMolecular Analysis of Patients With Neuromuscular Disease
- Where
- Boston
- Age
- 1 week to 100 years
- People
- 1,000
- Run by
- Boston Children's Hospital
See details and how to joinNCT00390104